|
Volumn 20, Issue 9, 2008, Pages 714-716
|
Promoting Collaboration between Adult and Paediatric Clinical Trial Groups
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TEMOZOLOMIDE;
ACCIDENTAL DEATH;
ADJUVANT THERAPY;
ADULT;
ADVANCED CANCER;
ASTROCYTOMA;
AUTOMUTILATION;
BRAIN CANCER;
BRAIN TUMOR;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER GRADING;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER RELAPSE;
CANCER RESEARCH;
CANCER RISK;
CANCER SURVIVAL;
CAUSE OF DEATH;
CENTRAL NERVOUS SYSTEM TUMOR;
CHILD;
CHILDHOOD CANCER;
CLINICAL RESEARCH;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTRAST ENHANCEMENT;
CRANIOPHARYNGIOMA;
EDITORIAL;
ENVIRONMENTAL FACTOR;
GENETIC RISK;
GERM CELL TUMOR;
GLIOBLASTOMA;
GROUPS BY AGE;
HISTOPATHOLOGY;
HUMAN;
MEDULLOBLASTOMA;
NEUROECTODERM TUMOR;
NEUROSURGERY;
PATIENT CODING;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESEARCH SUBJECT;
RISK ASSESSMENT;
RISK FACTOR;
SURVIVAL TIME;
TEAMWORK;
UNITED KINGDOM;
ADOLESCENT;
AGE DISTRIBUTION;
BRAIN NEOPLASMS;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS AS TOPIC;
COOPERATIVE BEHAVIOR;
HUMANS;
INTERINSTITUTIONAL RELATIONS;
PEDIATRICS;
YOUNG ADULT;
|
EID: 52749088615
PISSN: 09366555
EISSN: None
Source Type: Journal
DOI: 10.1016/j.clon.2008.06.009 Document Type: Editorial |
Times cited : (4)
|
References (0)
|